acute graft versus host disease
Showing 1 - 25 of 25
Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)
Not yet recruiting
- Acute Graft Versus Host Disease
- Hematopoietic and Lymphoid System Neoplasm
- Fecal Microbiota Transplantation Capsule
- Placebo
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 6, 2023
Acute GVHD Trial (MTX, Corticosteroid)
Not yet recruiting
- Acute Graft Versus Host Disease
- (no location specified)
Jun 26, 2023
Acute GVHD Trial (Itolizumab, Methylprednisolone)
Not yet recruiting
- Acute Graft Versus Host Disease
- (no location specified)
Apr 10, 2023
Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)
Recruiting
- Acute Graft Versus Host Disease
- MSCTC-0010 Dose Escalation
-
Kansas City, KansasKansas University Cancer Center
Jan 30, 2023
Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)
Recruiting
- Acute Graft Versus Host Disease
- Hematopoietic and Lymphoid System Neoplasm
- Cholestyramine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 5, 2023
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Terminated
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Oct 18, 2022
Acute GVHD, Gastrointestinal Tract Acute GVHD, Severe Gastrointestinal Tract Acute GVHD Trial in Los Angeles (Fecal Microbiota
Not yet recruiting
- Acute Graft Versus Host Disease
- +3 more
- Fecal Microbiota Transplantation Capsule
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 16, 2022
Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)
Recruiting
- Acute Graft Versus Host Disease
- Steroid Refractory Graft Versus Host Disease
- BRD4 Inhibitor PLX51107
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 24, 2022
Acute GVHD Trial in Spain (Adult Allogeneic Mesenchymal cells from adipose tissue.)
Active, not recruiting
- Acute Graft Versus Host Disease
- Adult Allogeneic Mesenchymal cells from adipose tissue.
-
Pamplona, Navarra, Spain
- +5 more
Feb 1, 2022
Acute GVHD Trial in United States (natalizumab, steroids)
Active, not recruiting
- Acute Graft Versus Host Disease
-
Duarte, California
- +11 more
Oct 15, 2021
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Active, not recruiting
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Jul 19, 2021
Acute GVHD Trial in Houston (Exercise Intervention, Physical Performance Testing, Questionnaire Administration)
Terminated
- Acute Graft Versus Host Disease
- Exercise Intervention
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 25, 2021
GVHD, Acute GVHD, Chronic GVHD Trial in Atlanta (Autologous mesenchymal stromal cells (MSCs))
Completed
- Graft Versus Host Disease
- +2 more
- Autologous mesenchymal stromal cells (MSCs)
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Mar 2, 2021
Acute GVHD Trial in Houston (pentostatin for injection)
Terminated
- Acute Graft Versus Host Disease
- pentostatin for injection
-
Houston, TexasMD Anderson Cancer Center
Oct 21, 2020
Acute GVHD Trial in Milwaukee (Tocilizumab)
Terminated
- Acute Graft Versus Host Disease
-
Milwaukee, WisconsinFroedtert Hospital/Medical College of Wisconsin-Clinical Cancer
Jan 30, 2020
Markers of Inflammation in Hematopoietic Stem Cell Transplant
Completed
- Acute Graft Versus Host Disease
-
Chicago, IllinoisLurie Children's Hospital
Aug 28, 2019
Acute GVHD, Intestinal GVHD Trial in Winston-Salem (Budesonide, Methylprednisolone Sodium Succinate)
Withdrawn
- Acute Graft Versus Host Disease
- Intestinal Graft Versus Host Disease
- Budesonide
- Methylprednisolone Sodium Succinate
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 31, 2018
Acute GVHD Trial in Stanford (AbGn-168H)
Terminated
- Acute Graft Versus Host Disease
- AbGn-168H
-
Stanford, CaliforniaStanford University, School of Medicine
Mar 28, 2017
Acute GVHD Trial in Ann Arbor (Etanercept (Enbrel))
Completed
- Acute Graft Versus Host Disease
- Etanercept (Enbrel)
-
Ann Arbor, MichiganUniversity of Michigan
Dec 4, 2015
Acute GVHD Trial in Tampa (Tacrolimus (TAC), Methotrexate (MTX), Rapamycin (RAPA))
Completed
- Acute Graft Versus Host Disease
- Tacrolimus (TAC)
- +2 more
-
Tampa, FloridaH.Lee Moffitt Cancer Center
Jul 10, 2015
Acute GVHD Trial in Jerusalem (Methylprednisolone (Intra-arterial continuous infusion of corticosteroids))
Terminated
- Acute Graft Versus Host Disease
- Methylprednisolone (Intra-arterial continuous infusion of corticosteroids)
-
Jerusalem, IsraelHadassah Medical Organisation
Apr 19, 2015
Acute GVHD Trial in Houston (Recombinant Human Keratinocyte Growth Factor)
Terminated
- Acute Graft Versus Host Disease
- Recombinant Human Keratinocyte Growth Factor
-
Houston, TexasMD Anderson Cancer Center
Aug 1, 2012
PETCT for Diagnosing and Monitoring Acute GVHD
Unknown status
- Acute Graft Versus Host Disease
- PETCT
-
Petah-Tiqva, IsraelBMT unit, Rabin Medical Center, Beilinson Hospital
May 9, 2012
Acute GVHD Trial in Nijmegen, Rotterdam, Utrecht (IT-Combination)
Withdrawn
- Acute Graft Versus Host Disease
- IT-Combination
-
Nijmegen, Netherlands
- +2 more
Apr 28, 2009